Desisobutyryl ciclesonide
CAS : 161115-59-9
Ref. 3D-FD21205
| 1mg | Arrêté | ||
| 2mg | Arrêté | ||
| 5mg | Arrêté | ||
| 10mg | Arrêté | ||
| 25mg | Arrêté |
Informations sur le produit
Nom :
Desisobutyryl ciclesonide
Synonymes :
- (11b,16a)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dioneCIC-APCiclesonide active principle
- CIC-AP
- Pregna-1,4-diene-3,20-dione, 16,17-[(cyclohexylmethylene)bis(oxy)]-11,21-dihydroxy-, [11β,16α(R)]-
- Ciclesonide active principle
- Pregna-1,4-diene-3,20-dione, 16,17-[[(R)-cyclohexylmethylene]bis(oxy)]-11,21-dihydroxy-, (11β,16α)-
- (11β,16α)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
Description :
Desisobutyryl ciclesonide is a prodrug of ciclesonide, which is a potent and specific beta-adrenergic agonist. It has been shown to have a pharmacokinetic profile that is similar to the parent drug, with an elimination half-life of approximately six hours. Desisobutyryl ciclesonide is not metabolized by cytochrome P450 enzymes and has low oral bioavailability. The drug does not produce any significant adverse effects in animal studies when administered orally or intravenously.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
470.6 g/mol
Formule :
C28H38O6
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
